EDITOR'S LETTER

EYE ON CHINA

• Palm-Sized PCR Device for Rapid Real-Time Detection of Viruses
• Scientists Uncover New Mechanism for Diabetic Neuropathy
• Chi Med Initiates a Phase I/II Clinical Trial of Novel FGFR Inhibitor HMPL 453 in China
• Database Boosts Shanghai's Technology Aim
• Experts Emphasize Scientific and Technological Innovations in Agriculture
• China Enlists AI to Diagnose Breast Cancer
• Study Offers Clue to Memory Formation in the Brain
• China Signed Science Cooperation Agreement with Bolivia
• Biotechnology in China Hits 4 Trillion RMB in 2016
• A Novel Pathway: Adult Hippocampal Neurogenesis Linked to Depression Caused by Inflammation
• BGI Genomics Announces Pricing of Initial Public Offering

FEATURES

• Current and Emerging Diagnostic and Therapeutic Developments in Age-Related Macular Degeneration (AMD)
• International Collaborative Research Program focusing on Aging
• Anterior Segment Optical Coherence Tomography Angiography (OCTA)
• Clinical Trials in our Real World
• Ophthalmology Workforce Planning and Projection – A New Integrated Approach

SPOTLIGHTS

• Robots, A Potential Staple in Eye Surgery
• Interviews at Commonwealth Science Conference 2017
• Precision Medicine for Cancer Patients: Interview with Dr Allen Lai

INSIDE INDUSTRY

• First of Its Kind Treatment – Repatha^® (evolocumab) – Available to Address Unmet Needs in Patients with Uncontrolled LDL Cholesterol in Singapore
• Agilent Technologies Announces Revolutionary Triple Quadrupole Mass Spectrometer
• Bristol-Myers Squibb’s Opdivo (nivolumab) + Yervoy (ipilimumab) Regimen Receives Approval from Singapore’s Health Sciences Authority in Unresectable or Metastatic Melanoma [1]
• National Supercomputing Centre Singapore and Global Gene Corp Sign a Strategic Collaboration in Support of Singapore’s Precision Medicine Initiative
• Parkway Pantai Introduces New 3-D Mammography Technology in Singapore Developed by GE Healthcare with More Patient Comfort in Mind
• Philips and Singapore Institute of Advanced Medicine Holdings Sign Agreement to Open First-of-its-kind Oncology Center in Singapore
• Siemens Launches First Fully Integrated Digitalization Hub in Singapore

BIOBOARD

SINGAPORE

• Asia Pacific Medical Technology Association (APACMed) Announces Partnership with Duke-NUS Medical School’s Centre of Regulatory Excellence (CoRE), Pledging Joint Commitment to Promote Regulatory Convergence and Capacity Building Across the Region
• Guardian Partners with MyDoc to Address Singapore’s Population Health Needs through Integrating Technology and Self-Care

SINGAPORE & UNITED STATES

• CellMax Life’s Precision, Non-Invasive Cancer Testing Now Available throughout Southeast Asia through Asia Genomics

UNITED STATES

• 23-D Printed Models Could Improve Patient Outcomes in Heart Valve Replacements
• Promising Target to Protect Bone in Patients with Diabetes
• New Antibody Appears to Re-Activate Immune System in Cancer Therapy
• Combo Immunotherapy May Herald New Standard of Care for Kidney Cancer

JAPAN

• Chugai’s Bispecific Antibody “Emicizumab” Global Phase III Data in Patients with Haemophilia A with Inhibitors Published in The New England Journal of Medicine Online

RUSSIA & INDIA

• BIOCAD’s Rituximab Biosimilar to Receive Market Authorization Soon in India

CONFERENCE CALENDAR